{"disease":{"id":"parapsoriasis","name":"parapsoriasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02425826","title":"A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":221,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02502188","title":"Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Celgene","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}